FDA Approved: SPIRONOLACTONE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Spironolactone submitted by Mylan Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Edema
• Heart Failure
• Hypertension
• Liver Cirrhosis
• Nephrotic Syndrome

Drugs mentioned

• Spironolactone (spironolactone)

Snippet

SUPPL AP for SPIRONOLACTONE (SPIRONOLACTONE)